Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis
BACKGROUND: End-stage renal disease (ESRD) is the final stage of chronic kidney disease (CKD). In the clinic, Uremic Clearance Granules (UCG) are mainly used in the treatment of early CKD and stabilized renal function. However, the benefits and mechanisms of UCG on ESRD remain unclear. METHODS: Rats...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357387/ https://www.ncbi.nlm.nih.gov/pubmed/35946040 http://dx.doi.org/10.2147/DDDT.S364069 |
_version_ | 1784763703298621440 |
---|---|
author | Li, Xiaosheng Zheng, Jie Wang, Jian Tang, Xianhu Zhang, Fengxia Liu, Shufeng Liao, Yunqiang Chen, Xiaoqing Xie, Wenjuan Tang, Yang |
author_facet | Li, Xiaosheng Zheng, Jie Wang, Jian Tang, Xianhu Zhang, Fengxia Liu, Shufeng Liao, Yunqiang Chen, Xiaoqing Xie, Wenjuan Tang, Yang |
author_sort | Li, Xiaosheng |
collection | PubMed |
description | BACKGROUND: End-stage renal disease (ESRD) is the final stage of chronic kidney disease (CKD). In the clinic, Uremic Clearance Granules (UCG) are mainly used in the treatment of early CKD and stabilized renal function. However, the benefits and mechanisms of UCG on ESRD remain unclear. METHODS: Rats were randomly divided into four groups: sham group, model group, peritoneal dialysis (PD) group and UCG group. Except for the sham-operated group, ESRD was induced by 5/6 nephrectomy in the other three groups. The PD group and UCG group were then subjected to PD. In addition, the UCG group was given UCG by gavage when PD. Changes in body weight and final kidney weight of rats in each group were monitored. HE and Masson staining were performed to confirm the extent of renal fibrosis. Biochemical kits were used to detect blood urea nitrogen (BUN), serum and urine creatinine (Scr, Cre), and urine protein (UPr) levels. ELISA was used to detect the rats’ inflammatory responses. qRT-PCR, WB, and IHC were probed to determine the expression levels of NF-κB and MAPK. 16S rDNA sequencing was performed to analyze the composition of gut microbiota in rats. A liquid chromatograph-mass spectrometer was performed to reveal serum metabolomics changes. RESULTS: UCG increased renal volume and body weight, improved renal fibrosis. It enhanced renal function and decreased the levels of BUN, Scr, Upr, Cre, inflammatory responses, as well as NF-κB and MAPK expressions in renal and colon tissues of ESRD rats. The relative abundances of Bacteroidetes and Firmicutes changed in ESRD rats in response to UCG. Serum metabolomics was utilized to identify 70 differentiated metabolites, which were associated with D-glutamine and D-glutamate metabolism, and Phenylalanine metabolism. CONCLUSION: Our study confirmed that UCG alleviated ESRD by regulating p38 MAPK/NF-κB signaling pathway, microbial and metabolic profiles. |
format | Online Article Text |
id | pubmed-9357387 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-93573872022-08-08 Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis Li, Xiaosheng Zheng, Jie Wang, Jian Tang, Xianhu Zhang, Fengxia Liu, Shufeng Liao, Yunqiang Chen, Xiaoqing Xie, Wenjuan Tang, Yang Drug Des Devel Ther Original Research BACKGROUND: End-stage renal disease (ESRD) is the final stage of chronic kidney disease (CKD). In the clinic, Uremic Clearance Granules (UCG) are mainly used in the treatment of early CKD and stabilized renal function. However, the benefits and mechanisms of UCG on ESRD remain unclear. METHODS: Rats were randomly divided into four groups: sham group, model group, peritoneal dialysis (PD) group and UCG group. Except for the sham-operated group, ESRD was induced by 5/6 nephrectomy in the other three groups. The PD group and UCG group were then subjected to PD. In addition, the UCG group was given UCG by gavage when PD. Changes in body weight and final kidney weight of rats in each group were monitored. HE and Masson staining were performed to confirm the extent of renal fibrosis. Biochemical kits were used to detect blood urea nitrogen (BUN), serum and urine creatinine (Scr, Cre), and urine protein (UPr) levels. ELISA was used to detect the rats’ inflammatory responses. qRT-PCR, WB, and IHC were probed to determine the expression levels of NF-κB and MAPK. 16S rDNA sequencing was performed to analyze the composition of gut microbiota in rats. A liquid chromatograph-mass spectrometer was performed to reveal serum metabolomics changes. RESULTS: UCG increased renal volume and body weight, improved renal fibrosis. It enhanced renal function and decreased the levels of BUN, Scr, Upr, Cre, inflammatory responses, as well as NF-κB and MAPK expressions in renal and colon tissues of ESRD rats. The relative abundances of Bacteroidetes and Firmicutes changed in ESRD rats in response to UCG. Serum metabolomics was utilized to identify 70 differentiated metabolites, which were associated with D-glutamine and D-glutamate metabolism, and Phenylalanine metabolism. CONCLUSION: Our study confirmed that UCG alleviated ESRD by regulating p38 MAPK/NF-κB signaling pathway, microbial and metabolic profiles. Dove 2022-08-03 /pmc/articles/PMC9357387/ /pubmed/35946040 http://dx.doi.org/10.2147/DDDT.S364069 Text en © 2022 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Xiaosheng Zheng, Jie Wang, Jian Tang, Xianhu Zhang, Fengxia Liu, Shufeng Liao, Yunqiang Chen, Xiaoqing Xie, Wenjuan Tang, Yang Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis |
title | Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis |
title_full | Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis |
title_fullStr | Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis |
title_full_unstemmed | Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis |
title_short | Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis |
title_sort | effects of uremic clearance granules on p38 mapk/nf-κb signaling pathway, microbial and metabolic profiles in end-stage renal disease rats receiving peritoneal dialysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357387/ https://www.ncbi.nlm.nih.gov/pubmed/35946040 http://dx.doi.org/10.2147/DDDT.S364069 |
work_keys_str_mv | AT lixiaosheng effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT zhengjie effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT wangjian effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT tangxianhu effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT zhangfengxia effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT liushufeng effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT liaoyunqiang effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT chenxiaoqing effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT xiewenjuan effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis AT tangyang effectsofuremicclearancegranulesonp38mapknfkbsignalingpathwaymicrobialandmetabolicprofilesinendstagerenaldiseaseratsreceivingperitonealdialysis |